About
A clinician and drug-discovery specialist who co-founded Apcintex (acquired by Centessa Pharmaceuticals) and XO1 (acquired by Janssen), and chairs the Scientific Advisory Board of Vaderis Therapeutics. He previously practiced at Cambridge University Hospitals as Director of Investigative Sciences, focusing on thrombosis and blood coagulation research, and led several haematology societies.
Invests in
BiotechDigital HealthMedical Devices
Investments
Led
ApcintexXO1
Board seats
Vaderis Therapeutics
Per the firm's website.
Colleagues at Medicxi
Frequently asked questions
- Who is Trevor Baglin?
- A clinician and drug-discovery specialist who co-founded Apcintex (acquired by Centessa Pharmaceuticals) and XO1 (acquired by Janssen), and chairs the Scientific Advisory Board of Vaderis Therapeutics. He previously practiced at Cambridge University Hospitals as Director of Investigative Sciences, focusing on thrombosis and blood coagulation research, and led several haematology societies.
- Where does Trevor Baglin work?
- Trevor Baglin is Venture Advisor at Medicxi.
- What does Trevor Baglin invest in?
- Trevor Baglin invests in Biotech, Digital Health, Medical Devices.
- What boards does Trevor Baglin sit on?
- Trevor Baglin holds tracked board seats at Vaderis Therapeutics.
- What companies has Trevor Baglin invested in?
- Investments tracked here include Apcintex, XO1.
- Does Trevor Baglin lead rounds?
- Yes β Trevor Baglin has led 2 tracked investments.